Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| UCEC | Uterine Corpus Endometrial Carcinoma | D226Y | Missense | 2 |
| BLCA | Bladder urothelial carcinoma | D255N | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E317D | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E329Q | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E41K | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | L133F | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | M75I | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | Q368Q | Silent | 1 |
| BRCA | Breast invasive carcinoma | E202Q | Missense | 1 |
| BRCA | Breast invasive carcinoma | L174F | Missense | 1 |
| BRCA | Breast invasive carcinoma | S128F | Missense | 1 |
| COAD | Colon adenocarcinoma | G155S | Missense | 1 |
| COAD | Colon adenocarcinoma | G353G | Silent | 1 |
| COAD | Colon adenocarcinoma | L117I | Missense | 1 |
| COAD | Colon adenocarcinoma | M72I | Missense | 1 |
| COAD | Colon adenocarcinoma | N264S | Missense | 1 |
| COAD | Colon adenocarcinoma | T96T | Silent | 1 |
| ESCA | Esophageal carcinoma | F65V | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | A198E | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | L274L | Silent | 1 |
| HNSC | Head and Neck squamous cell carcinoma | S272* | Nonsense | 1 |
| KIRC | Kidney renal clear cell carcinoma | E330E | Silent | 1 |
| LGG | Brain Lower Grade Glioma | T96R | Missense | 1 |
| LIHC | Liver hepatocellular carcinoma | K384K | Silent | 1 |
| LIHC | Liver hepatocellular carcinoma | S150S | Silent | 1 |
| LUAD | Lung adenocarcinoma | D217H | Missense | 1 |
| LUAD | Lung adenocarcinoma | D71Y | Missense | 1 |
| LUAD | Lung adenocarcinoma | G218V | Missense | 1 |
| LUAD | Lung adenocarcinoma | K295N | Missense | 1 |
| LUAD | Lung adenocarcinoma | S246G | Missense | 1 |
| OV | Ovarian serous cystadenocarcinoma | G155V | Missense | 1 |
| OV | Ovarian serous cystadenocarcinoma | P173S | Missense | 1 |
| OV | Ovarian serous cystadenocarcinoma | V291V | Silent | 1 |
| PAAD | Pancreatic adenocarcinoma | R67I | Missense | 1 |
| PRAD | Prostate adenocarcinoma | S76N | Missense | 1 |
| PRAD | Prostate adenocarcinoma | T56M | Missense | 1 |
| READ | Rectum adenocarcinoma | D71N | Missense | 1 |
| READ | Rectum adenocarcinoma | R371H | Missense | 1 |
| STAD | Stomach adenocarcinoma | E172G | Missense | 1 |
| STAD | Stomach adenocarcinoma | I238S | Missense | 1 |
| STAD | Stomach adenocarcinoma | P355L | Missense | 1 |
| STAD | Stomach adenocarcinoma | P356S | Missense | 1 |
| STAD | Stomach adenocarcinoma | R162Q | Missense | 1 |
| STAD | Stomach adenocarcinoma | T50K | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | E362D | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | E63K | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | K196T | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | L267I | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | Q328H | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | V314A | Missense | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 12.5 | 14.3 | 0 |
| BRCA | Breast invasive carcinoma | 976 | 0 | 7.1 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 0 | 0 | 0 |
| COAD | Colon adenocarcinoma | 367 | 25 | 9.5 | 0 |
| ESCA | Esophageal carcinoma | 185 | 0 | 2.4 | 0 |
| GBM | Glioblastoma multiforme | 283 | 0 | 0 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 12.5 | 2.4 | 100 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 12.5 | 0 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 0 | 0 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 0 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 0 | 2.4 | 0 |
| LIHC | Liver hepatocellular carcinoma | 373 | 25 | 0 | 0 |
| LUAD | Lung adenocarcinoma | 533 | 0 | 11.9 | 0 |
| LUSC | Lung squamous cell carcinoma | 177 | 0 | 0 | 0 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 12.5 | 4.8 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 0 | 2.4 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 0 | 0 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 0 | 4.8 | 0 |
| READ | Rectum adenocarcinoma | 122 | 0 | 4.8 | 0 |
| SARC | Sarcoma | 247 | 0 | 0 | 0 |
| SKCM | Skin Cutaneous Melanoma | 290 | 0 | 0 | 0 |
| STAD | Stomach adenocarcinoma | 393 | 0 | 14.3 | 0 |
| TGCT | Testicular Germ Cell Tumors | 147 | 0 | 0 | 0 |
| THCA | Thyroid carcinoma | 495 | 0 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 0 | 19 | 0 |